Cardiol Therapeutics Inc
NASDAQ:CRDL
Cardiol Therapeutics Inc
NASDAQ:CRDL
Price:
1.03
USD
3.52%
Market Closed
Market Cap:
$71.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Intrinsic Value
Not Available for CRDL
There is not enough data to reliably calculate the intrinsic value for Cardiol Therapeutics Inc.
Do our valuations actually work? See backtest results .
Alternatives to CRDL
Fundamental Analysis
What Cardiol Therapeutics Does
Cardiol Therapeutics is a drug development company focused on heart disease, especially inflammatory heart conditions. It is working on pharmaceutical versions of cannabidiol, or CBD, to treat conditions such as pericarditis and other forms of cardiac inflammation. Unlike a consumer cannabis company, it is trying to turn CBD into regulated prescription medicines that doctors could use in hospitals and clinics.
- Headquarters
- Canada CA
- Employees
- 18
- IPO date
- Dec 20, 2018
Financials
Revenue & Expenses Breakdown
Cardiol Therapeutics Inc
Cardiol Therapeutics Inc
Efficiency
Earnings Waterfall
Cardiol Therapeutics Inc
Cardiol Therapeutics Inc
